Christopher D Alafi - Net Worth and Insider Trading
Christopher D Alafi Net Worth
The estimated net worth of Christopher D Alafi is at least $384 Million dollars as of 2024-05-16. Christopher D Alafi is the Director of Intra-Cellular Therapies Inc and owns about 5,762,746 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $384 Million. Details can be seen in Christopher D Alafi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher D Alafi has not made any transactions after 2020-09-14 and currently still holds the listed stock(s).
Transaction Summary of Christopher D Alafi
Christopher D Alafi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher D Alafi owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of Christopher D Alafi’s form 4 insider trades.
Insider Ownership Summary of Christopher D Alafi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-09-14 | director & 10 percent owner |
| STXS | Stereotaxis Inc | 2004-08-11 | director & 10 percent owner |
Christopher D Alafi Latest Holdings Summary
Christopher D Alafi currently owns a total of 1 stock. Christopher D Alafi owns 5,762,746 shares of Intra-Cellular Therapies Inc (ITCI) as of September 14, 2020, with a value of $384 Million.
Latest Holdings of Christopher D Alafi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-09-14 | 5,762,746 | 66.61 | 383,870,918 |
Holding Weightings of Christopher D Alafi
Christopher D Alafi Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher D Alafi has made a total of 5 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Intra-Cellular Therapies Inc is the acquisition of 49,500 shares on September 14, 2020, which cost Christopher D Alafi around $1 Million.
Insider Trading History of Christopher D Alafi
- 1
Christopher D Alafi Trading Performance
GuruFocus tracks the stock performance after each of Christopher D Alafi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher D Alafi is 5.62%. GuruFocus also compares Christopher D Alafi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher D Alafi within 3 months outperforms 7 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher D Alafi's insider trading performs compared to the benchmark.
Performance of Christopher D Alafi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.76 | | | | | |
| Relative Return to S&P 500(%) | -5.92 | | | | | |
Christopher D Alafi Ownership Network
Christopher D Alafi Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Christopher D Alafi is the director & 10 percent owner of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include Chief Medical Officer Suresh K. Durgam , EVP & Chief Commercial Officer Mark Neumann , and VP of Finance & CFO & Secretary Lawrence J. Hineline .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Christopher D Alafi made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 237,827 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 237,827 shares. During the past 18 months, 1,382,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,382,842 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Christopher D Alafi Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher D Alafi. You might contact Christopher D Alafi via mailing address: P.o. Box 7338, Berkeley Ca 94707.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
